Edition:
United States

AquaBounty Technologies Inc (AQB.OQ)

AQB.OQ on NASDAQ Stock Exchange Capital Market

3.07USD
16 Jul 2018
Change (% chg)

$-0.05 (-1.60%)
Prev Close
$3.12
Open
$3.14
Day's High
$3.14
Day's Low
$3.07
Volume
1,487
Avg. Vol
23,907
52-wk High
$9.99
52-wk Low
$2.26

Chart for

About

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained,... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $39.76
Shares Outstanding(Mil.): 12.83
Dividend: --
Yield (%): --

Financials

  AQB.OQ Industry Sector
P/E (TTM): -- 214.97 33.20
EPS (TTM): -1.01 -- --
ROI: -33.82 -3.79 13.23
ROE: -37.64 -5.32 15.28

BRIEF-AquaBounty Technologies Posts Qtrly Loss Per Share Of $0.21

* AQUABOUNTY TECHNOLOGIES, INC. RESULTS FOR THE QUARTER ENDED MARCH 31, 2018

May 08 2018

BRIEF-Aquabounty Technologies, Inc. Announces FDA Approval Of First U.S. Facility For Commercial Production Of Aquadvantage Salmon

* AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES FDA APPROVAL OF FIRST U.S. FACILITY FOR COMMERCIAL PRODUCTION OF AQUADVANTAGE SALMON

Apr 27 2018

BRIEF-Aquabounty Technologies Files Mixed Shelf Of Up To $100 Mln

* AQUABOUNTY TECHNOLOGIES INC FILES MIXED SHELF OF UP TO $100 MLN - SEC FILING Source text: [https://bit.ly/2uQtjhb] Further company coverage:

Apr 06 2018

BRIEF-AquaBounty Technologies Results For The Year Ended December

* AQUABOUNTY TECHNOLOGIES, INC. RESULTS FOR THE YEAR ENDED DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

Mar 08 2018

Earnings vs. Estimates

No consensus analysis data available.